Suzuki M, Singh R, Moore M A, Song W R, Crystal R G
Division of Pulmonary and Critical Care Medicine, The New York Hospital-Cornell Medical Center, NY 10021, USA.
Hum Gene Ther. 1998 May 20;9(8):1223-31. doi: 10.1089/hum.1998.9.8-1223.
Replication-deficient adenovirus (Ad) vectors are effective in transferring genes in vivo, but their use is associated with significant variation in the extent and/or duration of expression observed among different strains of experimental animals and different routes of administration of the vector. We have minimized the variables of the heterologous transgene and animal-to-animal variation by constructing an Ad vector encoding murine thrombopoietin (mTPO, AdmTPO), a homologous protein that induces a physiologic response (elevation of blood platelet levels) that can be followed sequentially over time in the same animal. Using the C57BL/6 and BALB/c stains, liver administration was accomplished by intravenous administration and skeletal muscle administration by direct injection. Despite the use of a homologous cDNA as a transgene, the Ad genome was rapidly lost from the liver after intravenous administration over the first 1 to 2 weeks, with no difference in pattern of decline between the C57BL/6 and BALB/c strains. Both strains exhibited a cytotoxic T lymphocyte (CTL) response directed against the AdmTPO vector. Consistent with the decline in vector genome over time, the initial high levels of mTPO mRNA in the liver declined to an undetectable level within 2 weeks. Platelet counts peaked at 8- to 10-fold above baseline within the first 2 weeks, and then gradually declined, returning to normal level by 50 to 60 days. Intravenous administration of the AdmTPO vector to beta2-microglobulin-deficient mice resulted in a longer persistence of elevated platelets levels, although the eventual return of platelet levels to normal in these mice suggests the elimination of the Ad vector cannot be explained solely by CTL response. Although the intramuscular administration of the AdmTPO vector resulted in platelet levels with a lower peak and minor differences over time compared with the intravenous route, the C57BL/6 and BALB/c strains demonstrated the same rapid loss of Ad genome and mTPO mRNA levels in the muscle as in the liver. Together, these observations suggest that simplifying the experimental design by eliminating the variable of host response to a heterologous transgene, and by following the consequences of gene transfer in the same animals over time, there can be remarkable similarity in strain- and route-dependent responses to an Ad vector.
复制缺陷型腺病毒(Ad)载体在体内转移基因方面很有效,但在不同品系的实验动物以及载体的不同给药途径中,其使用与所观察到的表达程度和/或持续时间的显著差异相关。我们通过构建一种编码小鼠血小板生成素(mTPO,AdmTPO)的Ad载体,将异源转基因和动物个体差异的变量降至最低,mTPO是一种同源蛋白,可诱导一种生理反应(血小板水平升高),在同一只动物中可随时间顺序追踪该反应。使用C57BL/6和BALB/c品系,通过静脉注射完成肝脏给药,通过直接注射完成骨骼肌给药。尽管使用同源cDNA作为转基因,但在静脉注射后的最初1至2周内,Ad基因组在肝脏中迅速丢失,C57BL/6和BALB/c品系之间的下降模式没有差异。两个品系均表现出针对AdmTPO载体的细胞毒性T淋巴细胞(CTL)反应。与载体基因组随时间下降一致,肝脏中最初高水平的mTPO mRNA在2周内降至不可检测水平。血小板计数在最初2周内达到高于基线8至10倍的峰值,然后逐渐下降,在第50至60天恢复正常水平。向β2-微球蛋白缺陷小鼠静脉注射AdmTPO载体导致血小板水平升高的持续时间更长,尽管这些小鼠中血小板水平最终恢复正常表明Ad载体的消除不能仅用CTL反应来解释。尽管与静脉途径相比,AdmTPO载体的肌肉注射导致血小板水平峰值较低且随时间变化差异较小,但C57BL/6和BALB/c品系在肌肉中Ad基因组和mTPO mRNA水平的快速丢失与在肝脏中相同。总之,这些观察结果表明,通过消除宿主对异源转基因反应的变量,并随时间追踪同一只动物中基因转移的后果来简化实验设计,对Ad载体的品系依赖性和途径依赖性反应可能存在显著相似性。